SODIUM SULFITE

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
80.0 -1.0 0 3 63.0 0 0.0
UNII
VTK01UQK3G
CAS
7757-83-7
SYNONYMS
  • Sodium Sulfite
  • Sodium Sulfite Anhydrous
  • Natrum Sulphurosum
  • Sodium Sulphite Anhydrous
  • Sodium Sulphite
  • Natrum Sulphurosum [hpus]
  • Sodium Sulfite [mart.]
  • Sodium Sulfite [mi]
  • Sodium Sulfite [inci]
  • Sodium Sulfite [fcc]
  • Sodium Sulfite [ii]
  • Sodium Sulfite [hsdb]
  • Sodium Sulfite [vandf]
  • Anhydrous Sodium Sulphite
  • E-221
  • Ins-221
  • Ins No.221
  • Disodium Sulfite
  • S-Wat
ZINC ID(s)
Availability
Present in 0 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).

(Browse) Purchasable Analogs in ZINC

Dosages

Route Formulation Per Unit Dose
Auricular (otic) Solution 0.02%
Epidural Injection 0.1%
Im - Iv Injection 0.2%
Inhalation Solution 0.1%
Intra-Articular Injection 0.1%
Intralesional Injection
Intramuscular Injection 0.05%
Intravenous Injection 0.2%
Iv(infusion) Injection
Ophthalmic Solution 0.2%
Ophthalmic Solution, Drops 0.2%
Soft Tissue Injection
Subcutaneous Injection 0.15%
Topical Emulsion, Cream 0.2%
Oral Concentrate 0.03%
Oral Suspension
Oral Syrup

More Information

Usage Over Time

Comments